Advertisement

Topics

Small viruses could accelerate cell and gene therapy research

10:24 EST 8 Nov 2017 | Novartis

Interest in the field of genome editing continues to heat up, fueled by technological advances and the first approval of a gene therapy in the United States. The latest development in this exciting frontier of science involves small viruses called AAVs (short for adeno-associated viruses) that have the power to overwrite DNA in human cells. 

“AAV biology is one of the most febrile areas of basic research, and we’re planning to explore its therapeutic potential through a new collaboration,” says Craig Mickanin, who focuses on new tools and technologies as a director at the Novartis ...

Original Article: Small viruses could accelerate cell and gene therapy research

NEXT ARTICLE

More From BioPortfolio on "Small viruses could accelerate cell and gene therapy research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...